Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03450174
Other study ID # UniversityVAS
Secondary ID
Status Active, not recruiting
Phase N/A
First received January 25, 2018
Last updated February 22, 2018
Start date October 2, 2017
Est. completion date August 30, 2018

Study information

Verified date February 2018
Source University of Veterinary and Animal Sciences, Lahore - Pakistan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multiple micro-nutrient deficiencies in Pakistan is wide spread, there is dire need to address these by using smart solutions, among them multiple fortified product (fudge) is an alternate possible way to address this issue. Fortified products have the potential to reduce micronutrient deficiencies in children, therefore in current study children from 3-5 years will receive fortified product along with enhance nutrition promotional information to bring change in their dietary practices and nutritional indices.


Description:

As per the National Nutrition Survey, 2011 anaemia (iron deficiency) affected the children severely as one in three children under the age of 5 anemic, whereas prevalence of vitamin A deficiency among children under 5 years is more than 50%, similarly Zinc deficiency children and vitamin D deficiency prevalence in children is more than 40%.

The numerous indicators of nutrition deficiencies are related to inadequately nutritious and safe food, illiteracy, malpractices along with lack of nutritional knowledge and other social and behavioral issues. A healthy and supportive nutritional status, direct toward better intellect and earning of individual, which boost the social impact and macro level change.

Childhood stunting and deficiencies in iron and iodine hamper cognitive development, school achievement and adult productivity by 2.5-19.8 percent subsequently adult anemia reduces work performance in manual labor in the agriculture area and overall resultant US$ 7.6 billion annually loss for Pakistan, which corresponds to nearly 3 percent of GDP all due to poor nutritional indicators, which are preventable. Therefore, in developing countries like Pakistan, robust need is required, to do evidence base and translational research which could be easily converted into action that improves nutritional status.

Food fortification with micro-nutrients is effective, cost-efficient and medium-term approach to improve micro-nutrient status of vulnerable groups and is sustainable once established to prevent these at cheaper cost. There is need to investigate the positive effects of multiple micronutrient administration on child development along with there is dire need for more research to investigate it comprehensively at community level.

Fortified food products such as (milk, wheat, rice, oil, and other) are already in existing strategies worldwide to prevent micro-nutrient deficiencies in society which is well established and currently there are several extensive activities are implemented to prevent these hidden hunger but required results are not achieved.

On the other hand, other smart solutions are emerging to prevent these deficiencies at wider level in best possible means, among them fortified candy with multiple micronutrients is one vehicle. Confectionery products have the potential to carry the micronutrient for better delivery and doesn't significantly affect the flavour, taste and texture of the product.

The objective of the study is to determine the nutritional status, factor causing micronutrient deficiencies in pre-school children in semi-urban area of Karachi and how fortified product and enhance nutritional knowledge can bring change in nutritional indicators and understanding of nutrition in community.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 480
Est. completion date August 30, 2018
Est. primary completion date July 28, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 5 Years
Eligibility Inclusion Criteria:

- 3-5 years of age

- no medical complication

- from middle-income group within the semi-urban population

Exclusion Criteria:

- illness/ infections (TB, Malarial drug)

- non-attendant

- severe anemia/micro nutrient deficiency

- thyroid disease

- medication/supplementation

- not willing to participate

Study Design


Intervention

Dietary Supplement:
Placebo
In control group, participants will receive only a placebo product
Behavioral:
Formative messgaes
In this group, participants will only receive daily formative messages
Dietary Supplement:
Fortified product
In this group, participants will receive fortified product on alternate day up till 8 months
Combination Product:
Fortified product plus
In this group participants will receive fortified product on alternate day and formative messages up till 8 months

Locations

Country Name City State
Pakistan University of Veterinary and Animal Sciences Lahore Punjab

Sponsors (3)

Lead Sponsor Collaborator
University of Veterinary and Animal Sciences, Lahore - Pakistan PCSIR Laboratories Complex Karachi Pakistan, Sindh Lady Health Worker Program for Family Planning and Primary Health Care

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary To access the improvement in child Iron deficiency anemia change in serum Hemoglobin, serum ferritin and serum transferrin receptors Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months)
Primary To access the improvement in children Vitamin A status Change in Serum retinol binding protein Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months)
Primary To access the improvement in children Zinc status Change in serum zinc Will be accessed at Base-line (at start), Mid-line (after 4 months) and End-line (8 months)
Secondary Difference in the children anthropocentric status Mean z-scores (weight-for-age, length-for-age z-scores, weight-for-length) based on the WHO child growth standards 2006 Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start)
Secondary Effect on the household food security Diet diversity score based on dietary intake and preferences by 24 hrs dietary recall and Household Food Security Scale Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start)
Secondary Enhancement in the early childhood development indicators Gain change in the cognitive, motor and socio-emotional assessment through questionnaire filled by caretaker Base-line (at start, 0 month), Mid-line (after 4 months) and End-line (8 months at start)
See also
  Status Clinical Trial Phase
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05384691 - Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions Phase 2
Active, not recruiting NCT02101944 - Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Phase 1
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02930850 - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation N/A
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT03822884 - Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers Phase 1
Completed NCT02912494 - A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02912533 - A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) Phase 3
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01432717 - Study of ACE-536 in Healthy Postmenopausal Women Phase 1